[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100499531":3},{"organization":4,"armGroups":7,"interventions":17,"overallOfficials":23,"centralContacts":24,"locations":23,"responsibleParty":30,"collaborators":23,"id":32,"slug":33,"hasResults":34,"nctId":35,"briefTitle":36,"officialTitle":37,"acronym":38,"eligibilityCriteria":39,"healthyVolunteers":34,"sex":40,"minAge":41,"maxAge":23,"enrollmentInfo":42,"targetDuration":23,"studyType":45,"phases":46,"briefSummary":48,"conditions":49,"keywords":53,"overallStatus":57,"whyStopped":23,"lastUpdateSubmitDate":58,"lastUpdatePostDateStruct":59,"startDateStruct":62,"completionDateStruct":64,"leadSponsor":66,"locationsCount":23},{"fullName":5,"class":6},"Arizona State University","OTHER",[8,13],{"label":9,"type":6,"description":10,"interventionNames":11},"English","Participants in the English arm will receive the eMPrISe intervention materials in English.",[12],"Behavioral: Methamphetamine, PrEP, and Intersectional Stigma (eMPrISe) study",{"label":14,"type":6,"description":15,"interventionNames":16},"Spanish","Participants in the English arm will receive the eMPrISe intervention materials in Spanish.",[12],[18],{"type":19,"name":20,"description":21,"armGroupLabels":22,"otherNames":23},"BEHAVIORAL","Methamphetamine, PrEP, and Intersectional Stigma (eMPrISe) study","Group behavioral intervention with 12 weekly sessions lasting 2 hours focusing on coping, resistance, and resilience.",[9,14],null,[25],{"name":26,"role":27,"phone":28,"phoneExt":23,"email":29},"Angel B Algarin, PhD, MPH","CONTACT","(602) 496-0845","angel.algarin@asu.edu",{"type":31,"investigatorFullName":23,"investigatorTitle":23,"investigatorAffiliation":23,"oldNameTitle":23,"oldOrganization":23},"SPONSOR","100499531","methamphetamine-prep-and-intersectional-stigma-study-100499531",false,"NCT05784467","Methamphetamine, PrEP, and Intersectional Stigma Study","Addressing Intersectional Stigma Through Coping, Resistance, and Resilience to Improve Methamphetamine Use and Factors Influencing PrEP Uptake Among Latino MSM: a Step Towards Ending HIV by 2030","eMPrISe","Inclusion Criteria:\n\n* 18+ years of age\n* cisgender male\n* self-identify as Latino or Hispanic\n* fluent in English or Spanish\n* any sexual activity with men in the past 12 months\n* HIV-negative\n* moderate methamphetamine use risk (as determined by the the ASSIST assessment)\n* experience of intersectional stigma within their social network in the past 12 months\n* willing to provide written informed consent\n\nExclusion Criteria:\n\n* N\u002FA","MALE","18 Years",{"count":43,"type":44},20,"ESTIMATED","INTERVENTIONAL",[47],"NA","The goal of this clinical trail is to test the developed eMPrISe study in HIV-negative, adult, Latino men who have sex with men (MSM) who use non-injection substances. The main questions it aims to answer are:\n\n* Can participation in the developed eMPrISe study reduce methamphetamine ('meth') use risk?\n* Can participation in the developed eMPrISe study improve preexposure prophylaxis (PrEP) cascade progression? Participants will participate in 12 weekly modules that: (1) build critical thinking skills, (2) identify and discuss the link between oppression and harmful behaviors, (3) take action, (4) voice and validate feelings and experiences, and (5) share knowledge and resources.",[50,51,52],"Methamphetamine Abuse","Hiv","Social Stigma",[54,55,56],"Methamphetamine","Preexposure prophylaxis","Intersectional Stigma","NOT_YET_RECRUITING","2026-02-17",{"date":60,"type":61},"2026-02-19","ACTUAL",{"date":63,"type":44},"2026-04-15",{"date":65,"type":44},"2027-08-31",{"name":5,"class":6}]